Active Not Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT04322006

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

A Phase I/II Study of Evaluating the Safety, Tolerance, Pharmacokinetics, Pharmacodynamics and Curative Effect of Dose Escalation and Extension for Single Drug TJ004309 and Toripalimab Combine Treatment for Advanced Solid Tumor

Sponsor: TJ Biopharma Co., Ltd.

Conditions Advanced Solid Tumor

Interventions TJ004309 Toripalimab

Updated 19 times since 2020 Last updated: May 21, 2025 Started: May 9, 2020 Primary completion: Dec 30, 2025 Completion: Dec 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04322006, this PHASE1/PHASE2 trial focuses on Advanced Solid Tumor and remains ongoing. Sponsored by TJ Biopharma Co., Ltd., it has been updated 19 times since 2020, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

19 versions recorded

Jun 2025 — Present [monthly]

Active Not Recruiting PHASE1/PHASE2
May 2025 — Jun 2025 [monthly]

Active Not Recruiting PHASE1/PHASE2
Sep 2024 — May 2025 [monthly]

Active Not Recruiting PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
May 2024 — Jul 2024 [monthly]

Active Not Recruiting PHASE1_PHASE2

Status: Recruiting → Active Not Recruiting

▶ Show 14 earlier versions

Apr 2023 — May 2024 [monthly]

Recruiting PHASE1_PHASE2
Nov 2022 — Apr 2023 [monthly]

Recruiting PHASE1_PHASE2
Sep 2022 — Nov 2022 [monthly]

Recruiting PHASE1_PHASE2
May 2022 — Sep 2022 [monthly]

Recruiting PHASE1_PHASE2
Feb 2022 — May 2022 [monthly]

Recruiting PHASE1_PHASE2
Dec 2021 — Feb 2022 [monthly]

Recruiting PHASE1_PHASE2
Mar 2021 — Dec 2021 [monthly]

Recruiting PHASE1_PHASE2
Jan 2021 — Mar 2021 [monthly]

Recruiting PHASE1_PHASE2
Oct 2020 — Jan 2021 [monthly]

Recruiting PHASE1_PHASE2
Sep 2020 — Oct 2020 [monthly]

Recruiting PHASE1_PHASE2
Jul 2020 — Sep 2020 [monthly]

Recruiting PHASE1_PHASE2

Status: Enrolling By Invitation → Recruiting
Jun 2020 — Jul 2020 [monthly]

Enrolling By Invitation PHASE1_PHASE2

Status: Not Yet Recruiting → Enrolling By Invitation
May 2020 — Jun 2020 [monthly]

Not Yet Recruiting PHASE1_PHASE2
Apr 2020 — May 2020 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

TJ Biopharma Co., Ltd.

Data source: TJ Biopharma Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Changchun, China , Changsha, China , Chengdu, China , Chongqing, China , Guangzhou, China , Haerbin, China , Hanzhou, China , Hefei, China , Kunming, China and 9 more locations